Abstract：
:Introduction: The greater interest in TAAR1-mediated potential for the treatment of different pathologies, especially those related to CNS disorders, has given a considerable boost to the search for developing TAAR1-selective small molecules.Areas covered: During the last decade, the medicinal chemistry efforts have allowed the yield of various chemotypes to be properly dressed toward TAAR1 receptor. The more relevant chemical features and structure-activity relationship studies on the TAAR1 ligands will be discussed in order to guide future drug discovery investigations.Expert opinion: The discovery of TAAR receptors has allowed better investigation of the role played by TAs, not only as secondary neuromodulators, but also as neurotransmitters, even if it should still be completely clarified. This has drawn new ways for further insights around the TAAR1 involvement in numerous diseases. Despite this, the limited number of promising ligands targeting hTAAR1 orthologue makes the discovery of novel compounds still a challenging task. Relevant efforts have to be focused on safe ligands, devoid of any side-efficacy toward other highly related GPCR (monoaminergic systems). Moreover, species-specificity preferences experienced by numerous compounds so far investigated, based on rodent models and translated to the human environment, turn in a critical bottleneck in drug discovery.
journal_name
Expert Opin Ther Patjournal_title
Expert opinion on therapeutic patentsauthors
Tonelli M,Cichero Edoi
10.1080/13543776.2020.1708900subject
Has Abstractpub_date
2020-02-01 00:00:00pages
137-145issue
2eissn
1354-3776issn
1744-7674journal_volume
30pub_type
杂志文章,评审abstract：INTRODUCTION:New drug formulations against hypertension have a vital role in the quality of human life, as this risk factor for cardiovascular disease can be life threatening. A modern life style characterized by less exercise, smoking, drinking and poor diet has increased the risk of developing hypertension, the so-ca...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2015.1086337
更新日期：2015-01-01 00:00:00
abstract：INTRODUCTION:Around 3% of the world population is infected with HCV, with 3 - 4 million newly infected subjects added to this reservoir every year. At least 10% of these people will develop liver cirrhosis or cancer over time, while no approved vaccine against HCV infection is available to date. AREAS COVERED:This pap...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2011.630662
更新日期：2011-12-01 00:00:00
abstract：BACKGROUND:The application is in the field of neural stem cells (NSCs) and cellular therapy. OBJECTIVE:It aims at establishing conditions for the isolation and propagation of neural progenitor and stem cells from human fetal tissue, with high rate of growth and high yields of differentiation into the neuronal, astrogl...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章
doi：10.1517/13543770802688909
更新日期：2009-03-01 00:00:00
abstract：INTRODUCTION:New classes of synthetic and semi-synthetic β-glucan inhibitors have recently emerged, providing analogs that, in some cases, have been proven to have a high degree of activity against fungi, offering the prospect of alternatives to the commercially available lipopeptide/echinocandin agents caspofungin, mi...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2011.603899
更新日期：2011-10-01 00:00:00
abstract：:The interaction between p53 and murine double minute 2 (MDM2) provides an attractive drug target in oncology. Small molecule inhibitors of this interaction have not only provided strong evidence for blocking the protein-protein interaction, but are also extremely useful as biological probes and ultimately as novel the...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章
doi：10.1517/13543776.16.2.165
更新日期：2006-02-01 00:00:00
abstract：INTRODUCTION:Due to the role of bradykinin B1 receptor (B1R) in pain and inflammation, B1R antagonists have been suggested as promising drug candidates in chronic pain states. The first disclosed B1R antagonists were peptidomimetics, however, during the last few years, novel chemotypes with improved pharmacodynamic and...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2012.730521
更新日期：2012-12-01 00:00:00
abstract：INTRODUCTION:Benzoxaborole is a versatile boron-heterocyclic scaffold which has found in the last 10 years a broad spectrum of applications in medicinal chemistry, due to its physicochemical and drug-like properties. Use of benzoxaborole moiety in the design of compounds led to the discovery of new classes of anti-bact...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1080/13543776.2018.1473379
更新日期：2018-06-01 00:00:00
abstract：:Introduction: DNA-dependent protein kinase (DNA-PK) plays a crucial role in the repair of DSBs via non-homologous end joining (NHEJ). Several DNA-PK inhibitors are being investigated for potential anticancer treatment in clinical trials. Area covered: This review aims to give an overview of patents published since 201...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章
doi：10.1080/13543776.2021.1866540
更新日期：2020-12-21 00:00:00
abstract：:Introduction: The most conventional drug delivery systems exist with limitations such as drug degradation, toxicity and low bioavailability. Also, hypodermic injections can cause pain, compromising patient compliance. Due to this, transdermal drug delivery systems can minimize several problems associated with conventi...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1080/13543776.2020.1742324
更新日期：2020-06-01 00:00:00
abstract：INTRODUCTION:There is an unmet need of strategies for ex-vivo expansion of hematopoetic stem cells (HSCs) without loss of their primitive nature or stemness. We evaluate here a patent that attempts to address this need via key small molecules 1 and 40 that possess a pyrimido[4,5-b]indole core. Areas covered: (i) Discus...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章
doi：10.1080/13543776.2017.1360281
更新日期：2017-11-01 00:00:00
abstract：INTRODUCTION:The oxadiazoles represent a class of five-membered heterocyclic compounds which are of considerable interest in different areas of medicinal chemistry and drug discovery. Oxadiazoles can exist in different regioisomeric forms and employ in various agents with a broad range of biological activities. This re...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2013.797409
更新日期：2013-09-01 00:00:00
abstract：BACKGROUND:Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin it produces. Hyperglycemia, or raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body's systems, ...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543770903153878
更新日期：2009-10-01 00:00:00
abstract：INTRODUCTION:Piperine is a simple and pungent alkaloid found in the seeds of black pepper (Piper nigrum). Following its isolation and full characterization, the biological properties of piperine have been extensively studied, and piperine-like derivatives have shown an interesting range of pharmacological activities. I...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2016.1118057
更新日期：2016-01-01 00:00:00
abstract：INTRODUCTION:Tropomyosin receptor kinases (TrkA/B/C) play crucial roles in the development and maintenance of the nervous system, and aberrant expression of Trk has been implicated in neurological disorders as well as neural and non-neural neoplasms. Patent activity encompassing Trk inhibitors has grown substantially o...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1080/13543776.2017.1297796
更新日期：2017-06-01 00:00:00
abstract：INTRODUCTION:Amino acid depletion in the blood serum is currently being exploited and explored for therapies in tumors or viral infections that are auxotrophic for a certain amino acid or have a metabolic defect and cannot produce it. The success of these treatments is because normal cells remain unaltered since they a...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1080/13543776.2017.1254194
更新日期：2017-03-01 00:00:00
abstract：INTRODUCTION:The Rho kinase/ROCK is critical in vital signal transduction pathways central to many essential cellular activities. Since ROCK possess multiple substrates, modulation of ROCK activity is useful for treatment of many diseases. AREAS COVERED:Significant progress has been made in the development of ROCK inh...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2014.863279
更新日期：2014-03-01 00:00:00
abstract：:Small-molecule ligands, amenable to positron emission tomography (PET) imaging of different types of neurodegenerative disease-associated amyloid deposits in the CNS of living patients, hold considerable promise for diagnostic purposes, as well as for monitoring disease progression and the effectiveness of treatments....
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章
doi：10.1517/13543776.2014.871526
更新日期：2014-03-01 00:00:00
abstract：:Introduction: TIM3 and PD-1 are checkpoint inhibitors in cancer that coordinate the downregulation of the proliferation of antigen-specific lymphocytes. There is a great need to discover and develop new therapies focused on inhibiting the action of TIM3 and PD-1 and consequently improving the immune response in the va...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1080/13543776.2019.1637422
更新日期：2019-08-01 00:00:00
abstract：INTRODUCTION:Dendrimers were widely used in cancer diagnosis and therapy during the past decade. The surface functionalities allow bioactive molecules such as imaging probes, therapeutic compounds, targeting ligands to be present on dendrimer surface in a multivalent fashion. In addition, the interior pockets as well a...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2013.761207
更新日期：2013-04-01 00:00:00
abstract：IMPORTANCE OF THE FIELD:c-Met kinase is the receptor for hepatocyte growth factor. Primarily expressed on epithelial and mesenchymal cells its normal function is associated with wound healing, liver regeneration and embryo development. However, dysregulation of c-Met through overexpression, gene amplification, mutation...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543770903514137
更新日期：2010-02-01 00:00:00
abstract：:This article evaluates a patent application from Solvay Pharmaceuticals, which claims spiro azepane-oxazolidinones as novel blockers of the voltage-gated potassium channel Kv1.3 for the treatment of diabetes, psoriasis, obesity, transplant rejection and T-cell mediated autoimmune diseases such as rheumatoid arthritis ...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章
doi：10.1517/13543776.2010.528392
更新日期：2010-12-01 00:00:00
abstract：INTRODUCTION:2,5-Diketopiperazines (DKPs) are cyclic dipeptides from two amino acids with or without further structural modifications in DKP nucleus. These DKPs demonstrated attractive bioactive diversity and potential in drug discovery. AREAS COVERED:This review summarized those bioactive DKPs in patents, and provide...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2013.828036
更新日期：2013-11-01 00:00:00
abstract：INTRODUCTION:There has been research on anticancer strategies which focus on disrupting a single malignant protein. One of the strategies is the inhibition of one protein, heat shock protein 90 (Hsp90). There are many reasons why Hsp90 protein is targeted by anticancer agents: maintenance of cellular homeostasis in org...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2013.780597
更新日期：2013-08-01 00:00:00
abstract：INTRODUCTION:Quantitative Structure-Activity Relationship (QSAR) models are becoming one of the most interesting fields for developing therapeutics and therapeutics related patents. At present, QSAR methodologies comprise a series of possibilities, including joining forces with machine learning methods and increasing e...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1080/13543776.2018.1475560
更新日期：2018-06-01 00:00:00
abstract：INTRODUCTION:The non-receptor tyrosine kinase, inducible tyrosine kinase (Itk), plays an important role in thymus(T)-cell signalling and the production of pro-inflammatory cytokines. Itk, and the other Tec family members, Rlk and Tec, are viewed as attractive drug targets for new agents for the treatment of autoimmune ...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2014.936381
更新日期：2014-09-01 00:00:00
abstract：BACKGROUND:The family of G-protein-coupled receptors (GPCRs) serves as the target for almost a third of currently marketed drugs and provides the predominant mechanism through which extracellular factors transmit signals to the cell. GPCRs have been proved to be good therapeutic targets for metabolic disorders. In rece...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543770802665717
更新日期：2009-02-01 00:00:00
abstract：INTRODUCTION:The N-acylhydrazone (NAH) moiety has been characterized as a privileged structure, capable of providing ligands points for more than one type of bioreceptor. Modifications of the subunits bonded to its acyl and imine functions resulted in several derivatives, which modulate a great diversity of molecular t...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2014.959491
更新日期：2014-11-01 00:00:00
abstract：:In recent years, the involvement of the Hedgehog (Hh) signaling pathway in various human diseases and dysfunctions has been clearly demonstrated. Smoothened (Smo), one of the upstream signal transducers, has been the most druggable target of the Hh pathway. However, the emergence of resistance to Smo inhibitors and th...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章
doi：10.1517/13543776.2016.1132309
更新日期：2016-01-01 00:00:00
abstract：:Increasing pharmacological studies have demonstrated that organic cation transporter 3 (OCT3) plays an important role in controlling the extracellular concentrations of released monoamine neurotransmitter, suggesting that OCT3 might be a promising target in the treatment of depression. As a consequence, compounds show...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章
doi：10.1080/13543776.2016.1180364
更新日期：2016-08-01 00:00:00
abstract：INTRODUCTION:The appetite stimulating effects of melanin-concentrating hormone (MCH) continues to be of high interest, and there is substantial support to investigate the use of MCH 1-receptor antagonists for the treatment of obesity. Other areas of potential use for MCH 1-receptor antagonists include depression and an...
journal_title：Expert opinion on therapeutic patents
pub_type： 杂志文章,评审
doi：10.1517/13543776.2011.575063
更新日期：2011-06-01 00:00:00
